A team of researchers from the Brigham and Women’s Hospital, Harvard Medical School and the Dana-Farber Cancer Institute in the U.S., and Shanghai Medical College of Fudan University in China, has found epigenetic markers associated with Alzheimer’s disease (AD). In their paper published in the journal Science Advances, the group describes studying methylation in skin cultures from patients with and without AD, and what they found.
Despite many years of effort and countless dollars spent, scientists have been unable to cure AD, the most common form of dementia—but they have learned a lot more about it. Prior research has shown that it is not a heritable disease, but…
